Vitamins, minerals & supplements Archive

The troubling symptoms of prostatitis, or inflammation of the prostate, accounts for roughly two million doctor visits every year. Fortunately, research advances are leading to some encouraging developments for men suffering from this condition.

Having an extremely low LDL level from aggressive cholesterol-lowering therapy was not associated with cognitive impairment, according to a 2024 study.

Anorexia of aging affects about one-quarter of older adults, and women more often than men. The condition is marked by diminished appetite and can prompt a breakdown of muscle and bone mass that can lead to frailty, falls, delayed recovery from illness or surgery, and earlier death. Risk factors include changes in smell and taste, swallowing problems, slower digestion, medications that lead to dry mouth, dental problems, cognitive decline, and loneliness or social isolation. Treatments can include exercising, boosting protein intake, and medications.

Rheumatoid arthritis (RA) affects two to three times as many women as men. Scientists are uncovering RA's potential genetic and hormonal underpinnings, which point to potential reasons why women are more vulnerable. The newest treatments, called Janus kinase (JAK) inhibitors, resulted from research that has teased out delicate differences in immune system pathways. They block numerous proteins that ramp up inflammation fundamental to RA. The wide array of drug options now available for RA help doctors personalize therapies to each patient.

There's no clear-cut answer about whether taking antihistamines for allergies increases dementia risk. Antihistamines have anticholinergic effects, which might increase the risk for dementia by blocking a particular brain neurotransmitter or increasing brain inflammation. But studies on whether there's any link between antihistamines and dementia have produced conflicting findings. Doctors advise taking the lowest antihistamine dose possible or using another medication for symptom relief.

High levels of Lp(a)-a fatty particle similar to LDL cholesterol-may double or triple a person's risk of a heart attack. About one in five adults may have elevated levels, which also raises the risk of stroke and aortic stenosis. Unlike LDL, which rises with age and is influenced by diet and exercise, Lp(a) remains largely constant over a person's lifetime, so a one-time test suffices for screening. Lp(a) testing is becoming more common now that five promising new Lp(a) therapies are in development.

After a heart attack or stent placement, people typically take a combination of aspirin and another antiplatelet drug. After one year, the new standard practice is to stop the aspirin, in contrast to the previous practice of stopping the other drug.